BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17047598)

  • 1. [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
    Belousov IuB; Erofeeva SB; Maneshina OA
    Kardiologiia; 2006; 46(8):36-48. PubMed ID: 17047598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K
    Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC; Ponikowski P; Kahan T;
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
    Borer JS; Fox K; Jaillon P; Lerebours G;
    Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
    Andrikopoulos G; Dasopoulou C; Sakellariou D; Tzeis S; Koulouris S; Kranidis A; Kappos K; Manolis AS
    Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):277-82. PubMed ID: 18221092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK; Gray D; Purcell H
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of I(f) current inhibition by ivabradine.
    Tardif JC
    Drugs; 2007; 67 Suppl 2():35-41. PubMed ID: 17999562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angina: Ivabradine for treatment of stable angina pectoris.
    de Silva R; Fox KM
    Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.